11 Jun 2019 07:00
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Capital Markets Day
The neuroscience technology company Cambridge Cognition Holdings plc (AIM: COG), which develops and markets neuroscience technologies to assess brain health, is pleased to announce that it will be hosting a Capital Markets Day on 13 June 2019 at 10am at the offices of finnCap, 60 New Broad Street, EC2M 1JJ.
The event will feature a series of presentations from Cambridge Cognition's management and senior leadership team focussing on the latest developments in the product and technology portfolios.
To register for the event please email IR@finncap.com
No new material information or update on current trading will be disclosed at the event.
Enquiries
Cambridge Cognition Holdings PLC Matthew Stork, Chief Executive Officer Nick Walters, Chief Financial Officer |
Tel: 01223 810 700 press@camcog.com |
finnCap Ltd (NOMAD and Joint Broker) Geoff Nash / Simon Hicks Alice Lane / Manasa Patil | Tel: 020 7220 0500 (Corporate Finance) (ECM) |
Dowgate Capital Limited (Joint Broker) David Poutney / James Serjeant | Tel: 020 3903 7715
|
IFC Advisory Ltd (Financial PR and IR) Tim Metcalfe / Miles Nolan / Zach Cohen | Tel: 020 3934 6630
|
About Cambridge Cognition
Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early, and reduce global R&D and healthcare costs.
For further information visit www.cambridgecognition.com
Cambridge Cog (COG)